The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Thompson Jaye since 2022.
This trader's CIK number is 1476971.
At the time of last reporting, Thompson Jaye was the VP Clinical Reg Affairs of Greenwich Lifesciences, Inc.. (stock ticker symbol GLSI).
Also see all insider trading activities at Greenwich Lifesciences, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | GLSI | 3,800 | $55,140 | 0 | $0 | 0 | $0 |
| 2023 | GLSI | 3,850 | $47,718 | 0 | $0 | 0 | $0 |
| 2022 | GLSI | 3,500 | $61,924 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-21 | GLSI | Buy | 1,000 | 12.91 | 12,910 |
| 2024-08-12 | GLSI | Buy | 800 | 13.85 | 11,080 |
| 2024-08-02 | GLSI | Buy | 1,000 | 15.15 | 15,150 |
| 2024-07-18 | GLSI | Buy | 1,000 | 16.00 | 16,000 |
| 2023-10-27 | GLSI | Buy | 500 | 8.57 | 4,285 |
| 2023-09-26 | GLSI | Buy | 600 | 8.71 | 5,226 |
| 2023-07-13 | GLSI | Buy | 250 | 9.49 | 2,372 |
| 2023-04-28 | GLSI | Buy | 250 | 11.22 | 2,805 |
| 2023-04-11 | GLSI | Buy | 1,000 | 11.87 | 11,870 |
| 2023-03-15 | GLSI | Buy | 250 | 12.71 | 3,177 |
| 2023-02-24 | GLSI | Buy | 250 | 15.39 | 3,848 |
| 2023-02-03 | GLSI | Buy | 250 | 20.84 | 5,210 |
| 2023-01-27 | GLSI | Buy | 250 | 19.20 | 4,800 |
| 2023-01-13 | GLSI | Buy | 250 | 16.50 | 4,125 |
| 2022-12-16 | GLSI | Buy | 250 | 12.94 | 3,235 |
| 2022-12-02 | GLSI | Buy | 250 | 13.98 | 3,495 |
| 2022-04-19 | GLSI | Buy | 500 | 16.74 | 8,370 |
| 2022-01-31 | GLSI | Buy | 500 | 18.47 | 9,235 |
| 2022-01-21 | GLSI | Buy | 500 | 16.33 | 8,164 |
| 2022-01-18 | GLSI | Buy | 500 | 18.87 | 9,435 |
| 2022-01-13 | GLSI | Buy | 1,000 | 19.99 | 19,990 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Thompson Jaye (VP Clinical Reg Affairs of Greenwich Lifesciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.